Dystonia (focal and generalised)
Sustained abnormal postures · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A movement disorder of sustained or intermittent muscle contractions causing twisting postures and repetitive movements, ranging from focal (cervical dystonia, blepharospasm, writer's cramp) to generalised forms. Botulinum toxin is first-line for most focal dystonias.
Red flags
- Rapidly progressive or generalising dystonia
- Dystonic storm/status dystonicus (fever, rhabdomyolysis)
- Bulbar or respiratory involvement
- Underlying Wilson's disease missed
- Fixed dystonia suggesting functional aetiology or structural cause
Assessment
Differential diagnosis
- Secondary dystonia (Wilson's disease, drug-induced, structural lesion)
- Functional (psychogenic) dystonia
- Spasticity
- Tardive dystonia
- Parkinsonism with dystonia
- Dopa-responsive dystonia
Investigations
- MRI brain to exclude structural or basal ganglia lesion
- Copper studies (caeruloplasmin, 24h urinary copper) in young patients to exclude Wilson's
- Medication review for dopamine-blocker exposure
- Genetic testing for early-onset or generalised dystonia
- Levodopa trial if dopa-responsive dystonia possible
Management
- Classify dystonia by distribution, age of onset and whether primary or secondary
- Exclude Wilson's disease in any patient under 50 and drug-induced causes
- Trial levodopa in childhood-onset or diurnally fluctuating dystonia to exclude dopa-responsive dystonia
- Offer botulinum toxin injections as first-line for focal dystonias
- Add oral agents (anticholinergics, baclofen) for generalised or inadequately controlled dystonia
- Provide physiotherapy and sensory-trick training
- Refer generalised or refractory dystonia for deep brain stimulation assessment
- Treat associated pain and functional impact
- Address psychological comorbidity
- Review response and re-inject botulinum toxin every 10-12 weeks
Drugs & doses
Botulinum toxin A injection to affected muscles every 10-12 weeks
Trihexyphenidyl 1 mg PO daily titrated to 6-15 mg/day (anticholinergic)
Baclofen 5 mg PO TDS titrated upward
Levodopa/carbidopa trial for dopa-responsive dystonia
Clonazepam 0.5 mg PO nocte
Tetrabenazine for tardive dystonia
Disposition
Outpatient movement disorder clinic for botulinum toxin. Tertiary referral for DBS in generalised/refractory disease. Emergency admission for status dystonicus.
Complications & pitfalls
- Chronic pain and disability
- Status dystonicus with rhabdomyolysis and respiratory failure
- Anticholinergic side effects
- Botulinum toxin weakness or dysphagia (cervical injections)
- Secondary depression
Exam pearls
- Always trial levodopa in young-onset dystonia; dopa-responsive dystonia is dramatically treatable
- Exclude Wilson's disease in anyone under 50 with dystonia
- A sensory trick (geste antagoniste) supports a diagnosis of organic dystonia
- Status dystonicus is a neurological emergency needing ITU and sedation
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.